Amicus Therapeutics (FOLD) Sees IPO Pricing Between $14-16 Per Share
Tweet Send to a Friend
Amicus Therapeutics (Nasdaq: FOLD) has filed an amended S-1 statement with the SEC. The Company expects the public offering price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
